1. Home
  2. NTST vs HROW Comparison

NTST vs HROW Comparison

Compare NTST & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$20.08

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$35.25

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
HROW
Founded
2019
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NTST
HROW
Price
$20.08
$35.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
8
Target Price
$21.15
$71.14
AVG Volume (30 Days)
1.2M
936.9K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
4.37%
N/A
EPS Growth
150.00
N/A
EPS
0.08
N/A
Revenue
$195,006,000.00
N/A
Revenue This Year
$15.47
$44.68
Revenue Next Year
$14.57
$40.71
P/E Ratio
$251.25
N/A
Revenue Growth
19.79
N/A
52 Week Low
$14.00
$20.85
52 Week High
$21.30
$54.98

Technical Indicators

Market Signals
Indicator
NTST
HROW
Relative Strength Index (RSI) 49.84 32.18
Support Level $17.67 $30.55
Resistance Level $21.30 $40.64
Average True Range (ATR) 0.38 2.43
MACD -0.16 -1.01
Stochastic Oscillator 9.92 8.09

Price Performance

Historical Comparison
NTST
HROW

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: